SS
MDGL icon

Steve Schonfeld’s Madrigal Pharmaceuticals MDGL Stock Holding History

Steve Schonfeld’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1,000K Buy
+1,862
New +$954K ﹤0.01% 1481
2025
Q2 		– Sell
-5,580
Closed -$1.85M – 2336
2025
Q1 		$1.85M Buy
5,580
+55
+1% +$18.1K 0.01% 1002
2024
Q4 		$1.7M Sell
5,525
-40,569
-88% -$11.4M 0.01% 897
2024
Q3 		$9.78M Buy
46,094
+21,634
+88% +$5.53M 0.07% 307
2024
Q2 		$6.85M Buy
+24,460
New +$5.82M 0.04% 469
2024
Q1 		– Sell
-12,458
Closed -$2.88M – 2270
2023
Q4 		$2.88M Sell
12,458
-59,077
-83% -$10.3M 0.02% 684
2023
Q3 		$10.4M Buy
71,535
+51,670
+260% +$9.73M 0.08% 340
2023
Q2 		$4.59M Sell
19,865
-9,939
-33% -$2.69M 0.04% 513
2023
Q1 		$7.22M Buy
29,804
+15,204
+104% +$4.14M 0.07% 354
2022
Q4 		$4.24M Sell
14,600
-54,136
-79% -$5.29M 0.04% 529
2022
Q3 		$4.46M Buy
68,736
+56,389
+457% +$3.92M 0.04% 564
2022
Q2 		$884K Buy
+12,347
New +$908K 0.01% 1079
2022
Q1 		– Sell
-8,905
Closed -$754K – 2784
2021
Q4 		$754K Buy
8,905
+3,105
+54% +$255K 0.01% 1066
2021
Q3 		$463K Sell
5,800
-400
-6% -$34.5K ﹤0.01% 1310
2021
Q2 		$604K Sell
6,200
-24,254
-80% -$2.87M 0.01% 1104
2021
Q1 		$3.56M Buy
+30,454
New +$3.55M 0.04% 525
2020
Q4 		– Sell
-6,507
Closed -$773K – 1747
2020
Q3 		$773K Sell
6,507
-1,378
-17% -$150K 0.01% 778
2020
Q2 		$893K Sell
7,885
-36
-0.5% -$3.54K 0.02% 626
2020
Q1 		$529K Buy
+7,921
New +$660K 0.03% 561
2019
Q2 		– Sell
-2,700
Closed -$338K – 1153
2019
Q1 		$338K Sell
2,700
-28,200
-91% -$3.51M 0.01% 803
2018
Q4 		$3.48M Sell
30,900
-29,000
-48% -$4.49M 0.13% 216
2018
Q3 		$12.8M Buy
59,900
+54,000
+915% +$13.6M 0.57% 26
2018
Q2 		$1.65M Buy
5,900
+2,108
+56% +$370K 0.09% 304
2018
Q1 		$443K Buy
+3,792
New +$468K 0.03% 502

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Steve Schonfeld's MDGL Position: Q2 2026 in Review

Steve Schonfeld opened a new position in Madrigal Pharmaceuticals (MDGL) in Q2 2026: 1,862 shares worth $1,000K. The stake represents ﹤0.01% of the portfolio and ranks #1481 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in MDGL as recently as Q1 2025.

Steve Schonfeld first reported a position in MDGL in Q1 2018 and has held it in 24 quarters since. The position peaked at $12.8M in Q3 2018. 411 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Steve Schonfeld held 1,862 shares of Madrigal Pharmaceuticals worth $1,000K as of Q2 2026.
  • Madrigal Pharmaceuticals was a new Steve Schonfeld position in Q2 2026.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #1481 holding.
  • Steve Schonfeld first reported a position in Madrigal Pharmaceuticals in Q1 2018 and has held it in 24 quarters since.
  • Steve Schonfeld's Madrigal Pharmaceuticals position peaked at $12.8M in Q3 2018.
  • 411 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.